Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Aurinia Pharmaceuticals Inc.
| Metric | Aurinia Pharmaceuticals Inc. AUPHHealthcare |
|---|---|
| Quality Score | 100 / 100 |
| Revenue (latest) | $62M |
| Net income (latest) | $23M |
| Operating margin | 35.0% |
| Net margin | 37.4% |
| Return on equity | 4.0% |
| Return on assets | 3.1% |
| Return on capital (ROCE) | 3.3% |
| Debt / equity | 0.29× |
| Revenue growth (YoY) | 24.2% |
| Altman Z″ (distress) | 4.44 |
| Accruals / assets | −14.9% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.